USPTO serial 90597188
SHEPHERD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- EVANKO, PATRICIA MALESARDI
- Law office
- TMO LAW OFFICE 119 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with SHEPHERD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian J. Focarino
Brian J. Focarino COOLEY LLP1299 PENNSYLVANIA AVENUE, N.W.SUITE 700WASHINGTON, DC 20004Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for use in gene therapy, genetic medicines and regenerative therapies; pharmaceuticals and medical preparations and substances for genetically based diseases and rare disorders; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of diseases and disorders of the central nervous system; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of cancer; medicines for human purposes, namely, for treating genetically based diseases and disorders | ACTIVE | — |
| 009 | Downloadable podcasts in the field of promoting public interest and awareness of rare diseases; downloadable computer software in the nature of a mobile application to promote public interest and awareness of rare diseases; downloadable computer software for sharing, transmitting, storing, uploading, downloading, sending, and receiving information concerning rare diseases | ACTIVE | — |
| 035 | Promoting collaboration within the scientific, research, medical, and business communities to achieve advances in the field of healthcare; promoting collaboration within the scientific, research, medical provider, and business communities to achieve advances in the field of rare diseases; marketing campaign services in the nature of promoting public awareness among rare disease patients, caregivers, families, advocates, and friends; online retail store services featuring apparel and footwear; promoting public awareness of rare diseases and cancers by means of public advocacy; advertising and marketing consultancy; advertising, promotion, and marketing services in the nature of using social and digital media technology to find patients for medical providers and to connect patients to clinical studies; marketing consultation in the field of clinical trials; marketing consulting, namely, developing and monitoring social and digital media advertising campaigns in connection with clinical trials and patients with rare medical conditions; marketing services in the nature of conducting online, phone or in-person patient or physician market research; on-line advertising and marketing services; providing demand creation and lead generation activities and services; providing marketing consulting in the field of social media; business consulting and business management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business consulting and business management in the field of clinical trials, namely, providing information management services; providing advertising, marketing and promotional services for the pharmaceutical and medical industry; recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs | ACTIVE | — |
| 042 | Pharmaceutical research and development; Medical and scientific research, namely, conducting clinical trials for others; basic and clinical research in the field of health care and medicine; Clinical and medical research, data collection and scientific analysis to the pharmaceutical and health care industries in the fields of health, medical care and pharmaceutical efficacy; providing medical and scientific research information in the fields of pharmaceuticals, genetics and clinical trials; compiling scientific and clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of medicine, genetics, genetics medicines, regenerative medicines, gene therapy, biologics, and rare disease; operating, namely, creating and hosting an online community website relating to patients with rare diseases; pharmaceutical research services, namely, recruitment of rare disease patients for panels such as pharmaceutical research panels; design and development of computer software; platform as a service (PAAS) featuring computer software platforms for clinical trial patient lead management and enrollment; Platform as a service (PAAS) featuring computer software platforms for clinical trials; Platform as a service (PAAS) featuring computer software platforms for patient and physician market research; Platform as a service (PAAS) featuring computer software platforms for education about rare diseases and treatment received | ACTIVE | — |
| 044 | Health care services, namely, cancer therapy; providing a web site featuring medical information; providing a website featuring information in the field of the diagnosis and treatment of rare diseases; providing a website featuring information in the field of rare disease health; providing an internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; providing medical information to patients in the form of reports in the field of medicine and rare diseases; providing news and information in the field of medicine; providing educational information about healthcare | ACTIVE | — |
| 045 | Online social networking services for patient and caregiver communities | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SHEPHERD HEALTH, INC.
- Other trademarks owned by Shepherd Therapeutics, LLC
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named SHEPHERD
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 23, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 3, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Dec 11, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Dec 11, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Oct 4, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 4, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 4, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 31, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 8, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 21, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 30, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 30, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 30, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 17, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 17, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 17, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 20, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 20, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 20, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 19, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 28, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 26, 2021 | NWAP | NEW APPLICATION ENTERED | — |